Nocopi Technologies Announces 2025 Year-End Developments

Rhea-AI Summary

Nocopi Technologies (OTCQB: NNUP) announced year-end 2025 developments including a private placement, a new board appointment, product progress, and an expected SEC filing schedule. The company entered stock purchase agreements on December 31, 2025 to sell 266,666 shares at $1.50 per share to accredited investors, including affiliates of Horizon Kinetics. On December 15, 2025 the company appointed Eric Sites of Horizon Kinetics to its board. R&D advanced a patent-pending product, ColorBloom Molding Wax 2.0, with retail rollout expected in 2026. The company anticipates filing fiscal 2025 results and the annual report with the SEC in late March 2026.

Positive

• Completed private placement of 266,666 shares at $1.50 per share
• Added Eric Sites (Horizon Kinetics) to the Board of Directors
• Developed patent-pending ColorBloom Molding Wax 2.0 for retail launch
• Plans to file FY2025 financial results and annual report in late March 2026

Negative

• Product sales to certain Asian printers were negatively affected by U.S. tariff policy
• U.S. export uncertainty caused delays and lower Chinese product orders
• U.S. licensees have been selling down inventory rather than restocking

KING OF PRUSSIA, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. (“Nocopi Technologies” or the “Company”; OTCQB: NNUP), a developer of specialty reactive inks, announced the following 2025 year-end developments. The Company anticipates filing its fiscal year 2025 financial results and corresponding annual report with the SEC in late March. Nocopi Technologies’ SEC filings are available here.

New Appointment to the Board of Directors

On December 15, 2025, Nocopi Technologies appointed Eric Sites of investment management firm Horizon Kinetics Asset Management LLC ("Horizon Kinetics") to the Board of Directors.

Mr. Sites is a Vice President at Horizon Kinetics, which manages over $10 billion of AUM as of September 30, 2025. He joined Horizon Kinetics in 2004 and is a Portfolio Manager and Research Analyst. Horizon Kinetics utilizes a long horizon, value driven approach targeting absolute returns. Mr. Sites previously served as a Director for Canadian Securities Exchange, Bermuda Stock Exchange, Consensus Mining and Seigniorage Company, and Renn Fund. He is currently a Director of IL&FS Securities Services Ltd (ISSL) of India.

The Company welcomes Mr. Sites to the Board of Directors.

Private Placement

On December 31, 2025, Nocopi Technologies entered into stock purchase agreements with certain accredited investors, including certain affiliates of Horizon Kinetics, along with a current Nocopi Technologies board director, for the total purchase and sale of 266,666 shares of the Company's common stock at $1.50 per share.

Proceeds from the private placement will be used for general corporate purposes, including strengthening the Company’s balance sheet, supporting existing operations, and pursuing strategic growth opportunities.

Operational Updates

2025 presented a challenging environment that included inflation, tariff policies and a high degree of uncertainty that impacted the Company’s business in several ways. The Company’s business operations are solely based within the United States; however, the Company has multiple licensees and customers spanning Europe, South America, Asia and Australia. Over the last 12 months, product sales to certain Asian printers were negatively affected by the U.S. government tariff policy.

The uncertainty regarding timing and rates on exports to China resulted in delays as well as lower Chinese product orders, with many of the Company’s licensees in the U.S. selling down their inventory positions rather than actively restocking back up to the same historical inventory levels.

Going forward, the Company is hopeful that 2026 will offer more stability in the U.S. tariff position regarding China, which we expect should provide a more stable order environment where product orders from Chinese customers eventually normalize. We have already begun to see early signs of this occurring.

On the product development front, Nocopi Technologies’ Research & Development team worked throughout 2025 on developing a new patent pending product for the children’s entertainment market called ColorBloom Molding Wax 2.0. This new product was introduced to all our licensees, and early indications show that it was well accepted by some of Nocopi Technologies’ largest licensees in this market.

We expect the products to reach the retail market later this year. Given our early positive feedback on this complementary new product, the Company believes that it has the potential to become a great addition to our current product line.

Growth Acquisition Opportunities

The Company’s management continues to be focused on increasing long-term shareholder value. In doing so, management has continued to evaluate growth opportunities through the acquisition of other companies with competing or complementary services, technologies, or businesses. We ultimately measure our success by the growth of our free cash flow over time and have been focused on sourcing acquisition opportunities that fit such a profile.

About Nocopi Technologies (www.nocopi.com)

Nocopi Technologies, headquartered in King of Prussia, PA, develops and markets specialty reactive inks and licenses these technologies. Nocopi Technologies’ ink technologies are backed by proprietary and patented technology. Our inks are marketed for use across a variety of end markets.

Safe Harbor for Forward-Looking Statements
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve a number of estimates, assumptions, risks and uncertainties that may cause actual results to differ materially from those anticipated. Forward-looking statements may address uncertainties regarding customer preferences or demand for products incorporating Nocopi Technologies technology that underlie the Company’s revenue expectations, the Company’s ability to develop new products and new product applications, the financial condition of customers and the timeliness of their payments, the impact of fluctuations in currencies, global trade and shipping markets, other risks to which the Company is subject; other factors beyond the Company's control. Actual results could differ from those projected due to numerous factors and uncertainties, and Nocopi Technologies can give no assurance that such statements will prove to be correct nor that Nocopi Technologies’ actual results of ‎operations, financial condition and performance will not differ materially from those reflected or implied by its forward-‎looking statements. Investors should refer to the risk factors described by Nocopi Technologies in Item 1.A "Risk Factors" in its most recent Form 10-K and other SEC reports available at www.sec.gov/edgar. Forward-looking statements are made as of the date of this news release; Nocopi Technologies assumes no obligation to update these statements.

Investor & Media Contacts
610-834-9600
ir@nocopi.com

FAQ

What did Nocopi Technologies (NNUP) raise in the December 31, 2025 private placement?

Nocopi entered agreements to sell 266,666 shares at $1.50 per share to accredited investors, including Horizon Kinetics affiliates.

Who was appointed to Nocopi Technologies' board on December 15, 2025?

Eric Sites of Horizon Kinetics, a portfolio manager and research analyst, was appointed to the Board of Directors.

When will Nocopi Technologies file its fiscal 2025 results (NNUP)?

The company anticipates filing fiscal year 2025 financial results and the annual report with the SEC in late March 2026.

What is ColorBloom Molding Wax 2.0 and when will NNUP sell it?

ColorBloom Molding Wax 2.0 is a patent-pending children’s entertainment product introduced to licensees, expected to reach retail in 2026.

How did U.S. tariff policy affect Nocopi Technologies' 2025 sales?

U.S. tariff policy and export uncertainty led to reduced orders from Chinese customers and delays, hurting sales to some Asian printers.

What will Nocopi use the proceeds from the private placement for?

Proceeds will be used for general corporate purposes, including strengthening the balance sheet, supporting operations, and pursuing growth opportunities.